An upcoming paper describes that TP53INP1 is targeted by miRs 93 and 130b which were found to be overexpressed in both samples from patients suffering from acute ATLL and ATLL-derived cell lines [67]. Here, TP53INP1 is linked to adult T-cell leukemia/lymphoma.